{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:08:14Z","timestamp":1761527294937,"version":"build-2065373602"},"reference-count":34,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background\/Objectives: Access to genetic counselling and BRCA1\/2 germline testing is standard of care for patients with high-grade serous ovarian carcinoma (HGSOC). While tumour testing reliably detects pathogenic variants in hereditary cancer genes, it cannot distinguish somatic from germline variants. Concurrent testing of non-cancerous (normal) tissue obtained during surgery may improve triage for germline testing and clinical genetics referral. This study evaluated the concordance of inherited variant detection among tumour, normal tissue, and blood to determine whether archived normal tissue can reliably identify germline pathogenic variants. Methods: Patients with HGSOC who had a pathogenic variant identified by targeted Next Generation Sequencing (NGS) tumour testing and underwent germline hereditary cancer gene panel (HCP) testing between April 2019 and November 2020 were included. HCP testing was performed on formalin-fixed, paraffin-embedded normal tissue from the original resection. Variant results were compared across tumour, normal tissue, and germline (blood) samples to determine concordance, false-negative, and false-positive rates. Results: Forty-one patients had confirmed tumour variants in BRCA1\/2 or other HCP genes. Of these, 24 harboured a corresponding germline pathogenic variant. Archived normal tissue was available for 23 of these 24 cases, and all germline variants were detected in normal tissue, showing 100% concordance. Among the 17 patients without germline variants, all corresponding normal tissue samples were negative, also demonstrating 100% concordance. No false positives or negatives were identified. Conclusions: NGS testing of normal tissue at surgical resection reliably identifies germline pathogenic variants in patients with HGSOC. Incorporating this approach may help triage patients for clinical genetics assessment.<\/jats:p>","DOI":"10.3390\/genes16111260","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:51:42Z","timestamp":1761526302000},"page":"1260","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Examining the Concordance of Detection of Hereditary Cancer Gene Variants Between Blood, Tumour, and Normal Tissue in Patients with High-Grade Serous Ovarian Carcinoma"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4389-1614","authenticated-orcid":false,"given":"L.","family":"Mui","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1245-6606","authenticated-orcid":false,"given":"J.","family":"Kerkhof","sequence":"additional","affiliation":[{"name":"Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON N6A 5W9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"McLachlin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Department of Pathology and Laboratory Medicine, London Health Sciences Centre, London, ON N6A 5A5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Panabaker","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical Genetics, London Health Sciences Centre, London, ON N6A 5W9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"McGee","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, London Health Sciences Centre and Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5W9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sadikovic","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON N6A 5W9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Goebel","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Department of Pathology and Laboratory Medicine, London Health Sciences Centre, London, ON N6A 5A5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1200\/JCO.19.02960","article-title":"Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline","volume":"38","author":"Konstantinopoulos","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.seminoncol.2017.08.004","article-title":"Guidance Statement on BRCA1\/2 Tumor Testing in Ovarian Cancer Patients","volume":"44","author":"Capoluongo","year":"2017","journal-title":"Semin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2008.10.007","article-title":"Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based study","volume":"112","author":"Metcalfe","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/IGC.0000000000000907","article-title":"Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario","volume":"27","author":"McGee","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/jmedgenet-2018-105472","article-title":"Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: A Canadian multisociety roadmap","volume":"55","author":"McCuaig","year":"2018","journal-title":"J. Med. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jmoldx.2018.05.005","article-title":"Validation and Implementation of BRCA1\/2 Variant Screening in Ovarian Tumor Tissue","volume":"20","author":"Ruano","year":"2018","journal-title":"J. Mol. Diagn."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Goebel, E.A., Kerkhof, J., Dzyubak, O., McLachlin, C.M., McGee, J., and Sadikovic, B. (2022). Examining the Diagnostic Yield of Tumour Testing and Qualifying Germline Concordance for Hereditary Cancer Variants in Patients with High-Grade Serous Carcinoma. Genes, 13.","DOI":"10.3390\/genes13081398"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ajmg.a.61998","article-title":"Validation and clinical performance of a combined nuclear-mitochondrial next-generation sequencing and copy number variant analysis panel in a Canadian population","volume":"185","author":"Levy","year":"2021","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jmoldx.2017.07.004","article-title":"Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels","volume":"19","author":"Kerkhof","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s10038-020-0780-4","article-title":"Genetic and epigenetic profiling of BRCA1\/2 in ovarian tumors reveals additive diagnostic yield and evidence of a genomic BRCA1\/2 DNA methylation signature","volume":"65","author":"McGee","year":"2020","journal-title":"J. Hum. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e6661","DOI":"10.7717\/peerj.6661","article-title":"Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast\/ovarian cancer","volume":"7","author":"Nicolussi","year":"2019","journal-title":"PeerJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ejhg.2012.270","article-title":"Next-generation sequencing meets genetic diagnostics: Development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes","volume":"21","author":"Tornero","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Bartlett, J., Amemiya, Y., Arts, H., Bayani, J., Eng, B., Grafodatskaya, D., Reid, S.K., Lariviere, M., Lo, B., and McClure, R. (2021). Multisite verification of the accuracy of a multi-gene next generation sequencing panel for detection of mutations and copy number alterations in solid tumours. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0258188"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"155803","DOI":"10.1016\/j.prp.2024.155803","article-title":"BRCA1 and BRCA2 mutations testing in prostate cancer: Detection in formalin fixed paraffin embedded (FFPE) and blood samples","volume":"266","author":"Zannini","year":"2025","journal-title":"Pathol.-Res. Pract."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"154336","DOI":"10.1016\/j.prp.2023.154336","article-title":"Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types","volume":"243","author":"Zannini","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.molonc.2015.07.002","article-title":"Genotyping concordance in DNA extracted from formalin-fixed paraffin embedded (FFPE) breast tumor and whole blood for pharmacogenetic analyses","volume":"9","author":"Hertz","year":"2015","journal-title":"Mol. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Bhai, P., Turowec, J., Santos, S., Kerkhof, J., Pickard, L., Foroutan, A., Breadner, D., Cecchini, M., Levy, M.A., and Stuart, A. (2023). Molecular profiling of solid tumors by next-generation sequencing: An experience from a clinical laboratory. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1208244"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40291-022-00579-1","article-title":"Concordance Study of a 520-Gene Next-Generation Sequencing-Based Genomic Profiling Assay of Tissue and Plasma Samples","volume":"26","author":"Wang","year":"2022","journal-title":"Mol. Diagn. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10549-018-4798-7","article-title":"FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment","volume":"170","author":"Wilkins","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Oh, E., Choi, Y.-L., Kwon, M.J., Kim, R.N., Kim, Y.J., Song, J.-Y., Jung, K.S., and Shin, Y.K. (2015). Comparison of accuracy of whole-exome sequencing with formalin-fixed paraffin-embedded and fresh frozen tissue samples. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0144162"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/bio.2020.0021","article-title":"Nonmalignant Formalin-Fixed Paraffin-Embedded Tissues as a Source to Study Germline Variants and Cancer Predisposition: A Systematic Review","volume":"18","author":"Youssef","year":"2020","journal-title":"Biopreservation Biobanking"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jmoldx.2013.05.004","article-title":"Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens","volume":"15","author":"Spencer","year":"2013","journal-title":"J. Mol. Diagn."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2217\/14622416.6.8.873","article-title":"Concordance of pharmacogenetic markers in germline and colorectal tumor DNA","volume":"6","author":"Marsh","year":"2005","journal-title":"Pharmacogenomics"},{"key":"ref_26","unstructured":"Yap, S.Q. (2017). Germline Variant Calling in Formalin-Fixed Paraffin-Embedded Tumours. [Master\u2019s Thesis, University of British Columbia]."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10689-006-0003-y","article-title":"Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue","volume":"5","author":"Adank","year":"2006","journal-title":"Fam. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Cannon-Albright, L.A., Cooper, K.G., Georgelas, A., and Bernard, P.S. (2011). High quality and quantity Genome-wide germline genotypes from FFPE normal tissue. BMC Res. Notes, 4.","DOI":"10.1186\/1756-0500-4-159"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1158\/1055-9965.251.14.1","article-title":"Comparison of archival plasma and formalin-fixed paraffin-embedded tissue for genotyping in hepatocellular carcinoma","volume":"14","author":"Hoffmann","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/6029097","article-title":"Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The \u2018opt-Out\u2019 Process","volume":"2019","author":"McGee","year":"2019","journal-title":"J. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ejhg.2015.268","article-title":"Post-mortem testing; germline BRCA1\/2 variant detection using archival FFPE non-tumor tissue. A new paradigm in genetic counseling","volume":"24","author":"Petersen","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_32","unstructured":"Canadian Association of Pathologists (2024, October 24). The Retention and Use of Human Biologic Material. Available online: https:\/\/cap-acp.org\/general\/custom.asp?page=The-Retention-and-Use-of-Human-Biologic-Material."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-4608(98)00079-X","article-title":"Mutations in BRCA1 from fixed, paraffin-embedded tissue can be artifacts of preservation","volume":"107","author":"Wong","year":"1998","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/bio.2014.0010","article-title":"Paraffin Treasures: Do They Last Forever?","volume":"12","author":"Torres","year":"2014","journal-title":"Biopreservation Biobanking"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/11\/1260\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:04:47Z","timestamp":1761527087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/11\/1260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["genes16111260"],"URL":"https:\/\/doi.org\/10.3390\/genes16111260","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]}}}